- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02476474
GERD Following Laparoscopic Sleeve Gastrectomy
8. juni 2022 opdateret af: University of California, San Francisco
Antral Length and GERD Following Sleeve Gastrectomy for Morbid
Laparoscopic Sleeve Gastrectomy (LSG) creates a vertical gastrectomy which results in a narrow and tubular shape of stomach.
The line of resection starts at 3-6 cm.
from pylorus (antrum) toward to the angle of His.
The gastric antrum plays a major role in gastric emptying, particularly for solids.
Hence, depending upon the starting point of gastric sleeve resection in each center, this can result in difference of the remaining gastric antrum which may affect gastric emptying time after this procedure.
Studieoversigt
Status
Trukket tilbage
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Laparoscopic Sleeve Gastrectomy (LSG), a purely restrictive procedure, has become recently one of the most popular bariatric surgical procedures in this decade because its surgical technique is simple but outcomes in regards to weight loss and co-morbidities improvement are excellent comparable to other procedures.
Nevertheless, this procedure carries one potential drawback namely "gastroesophageal reflux disease (GERD).
The impact on GERD following LSG are inconsistent .
Additionally, the recent literature can be divided into two categories: those that support an increase in GERD prevalence after LSG and those that demonstrate a decrease in GERD prevalence after LSG.
Postoperatively, one of the proposed mechanisms for either increased or decreased GERD prevalence is gastric emptying time.
Delayed gastric emptying time can contribute to increase intra-gastric volume and pressure resulting in an increase in prevalence of GERD after surgery.
On the other hand, accelerated gastric emptying time can cause decrease in GERD prevalence because of decrease in stomach volume and interorgan pressure after operation.
In addition, LSG creates a vertical gastrectomy which results in a narrow and tubular shape of stomach.
The line of resection starts at 3-6 cm.
from pylorus (antrum) toward to the angle of His.
The gastric antrum plays a major role in gastric emptying, particularly for solids.
Hence, depending upon the starting point of gastric sleeve resection in each center, this can result in difference of the remaining gastric antrum which may affect gastric emptying time after this procedure.
The investigators hypothesize that a larger amount of gastric antrum will result in accelerated gastric emptying time which leads to less GERD prevalence.
On the contrary, the less the remaining gastric antrum would result in delayed gastric emptying which contribute to more GERD prevalence.
The investigators plan on identifying the prevalence of GERD in the patients who undergo LSG comparing those who have the sleeve beginning either 3 cm.
or 6 cm.
from pylorus.
We will utilize 24 hour esophageal pH monitoring, esophageal manometry, upper gastrointestinal scintigraphy and esophagogastroduodenoscopy at preoperatively, 3 and 6 month postoperatively.
Ultimately, this study will help further clarify the most proper starting resected point of LSG (3 versus 6 cm.
from pylorus) which results in the least GERD prevalence after surgery.
Undersøgelsestype
Interventionel
Fase
- Ikke anvendelig
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 70 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Any subject who has already been already cleared for and scheduled to undergo laparoscopic sleeve gastrectomy for the treatment of morbid obesity(Utilizing NIH1991 guideline for bariatric surgery)
Exclusion Criteria:
- Patients not meeting entry criteria to undergo bariatric surgery procedures.
- Refusal to give informed consent.
- Age <18 or >70.
- Prior small intestinal or gastric resective surgery
- Existing coagulopathy (INR>2.0, platelet count<100,000)
- Severe reflux esophagitis.( Los Angeles Classification for erosive esophagitis grade C,D)
- Hiatal hernia > 2 cm(according to esophageal manometry or EGD)
- Acquired or Congenital Immunodeficiencies
- White blood cell count below normal range.
- Azotemia - serum creatinine > 2.0 mg/dl
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: 3 cm start of resection
The line of resection for the Laparoscopic Sleeve gastrectomy will start at 3 cm from pylorus (antrum).
|
Investigators will start the resection of the LSG 3 centimeters from the antrum of the stomach.
|
|
Aktiv komparator: 6 cm start of resection
The line of resection for the Laparoscopic Sleeve gastrectomy will start at 6 cm from pylorus (antrum).
|
Investigators will start the resection of the LSG 6 centimeters from the antrum of the stomach.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Time of gastric emptying
Tidsramme: 6 months post surgery
|
6 months post surgery
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Number of participants with GERD
Tidsramme: 3 months
|
3 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Braghetto I, Davanzo C, Korn O, Csendes A, Valladares H, Herrera E, Gonzalez P, Papapietro K. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009 Nov;19(11):1515-21. doi: 10.1007/s11695-009-9954-z. Epub 2009 Aug 28.
- Bernstine H, Tzioni-Yehoshua R, Groshar D, Beglaibter N, Shikora S, Rosenthal RJ, Rubin M. Gastric emptying is not affected by sleeve gastrectomy--scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg. 2009 Mar;19(3):293-8. doi: 10.1007/s11695-008-9791-5. Epub 2008 Dec 17.
- Chiu S, Birch DW, Shi X, Sharma AM, Karmali S. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2011 Jul-Aug;7(4):510-5. doi: 10.1016/j.soard.2010.09.011. Epub 2010 Sep 21.
- Melissas J, Daskalakis M, Koukouraki S, Askoxylakis I, Metaxari M, Dimitriadis E, Stathaki M, Papadakis JA. Sleeve gastrectomy-a "food limiting" operation. Obes Surg. 2008 Oct;18(10):1251-6. doi: 10.1007/s11695-008-9634-4. Epub 2008 Jul 29.
- Laffin M, Chau J, Gill RS, Birch DW, Karmali S. Sleeve gastrectomy and gastroesophageal reflux disease. J Obes. 2013;2013:741097. doi: 10.1155/2013/741097. Epub 2013 Jul 15.
- Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve gastrectomy--influence of sleeve size and resected gastric volume. Obes Surg. 2007 Oct;17(10):1297-305. doi: 10.1007/s11695-007-9232-x.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Forventet)
1. juli 2023
Primær færdiggørelse (Forventet)
1. december 2023
Studieafslutning (Forventet)
1. december 2023
Datoer for studieregistrering
Først indsendt
3. juni 2015
Først indsendt, der opfyldte QC-kriterier
16. juni 2015
Først opslået (Skøn)
19. juni 2015
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
13. juni 2022
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
8. juni 2022
Sidst verificeret
1. juni 2022
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 133508
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Sygelig fedme
-
Ain Shams UniversityIkke rekrutterer endnuPostoperativ Respiration Dysfunktion | Morbid Overvægt hos Hjertekirurgiske Patienter | Mekaniske ventilationstrategier
Kliniske forsøg med 3 cm start of resection
-
Seoul National University HospitalAfsluttetPostoperativ atelektase | Videoassisteret thoraxkirurgi | Positivt slutekspiratorisk trykKorea, Republikken
-
Yale UniversityNational Cancer Institute (NCI)Afsluttet
-
Sohag UniversityIkke rekrutterer endnu
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell UniversityAfsluttetEndetarmskræft | for tarmdysfunktion efter operation for endetarmskræftForenede Stater
-
University Hospital, Basel, SwitzerlandAfsluttet
-
King's College Hospital NHS TrustAfsluttet
-
Istanbul Arel UniversityBahçeşehir University; Kırklareli UniversityAfsluttetNeurologiske underskudTyrkiet (Türkiye)
-
University of California, DavisNational Institute of Mental Health (NIMH); University of California, Los... og andre samarbejdspartnereAfsluttetAutismespektrumforstyrrelse | AutismeForenede Stater
-
Giancarlo NatalucciAktiv, ikke rekrutterende
-
The Miriam HospitalAfsluttetHIV-forebyggelse | Opioid-relaterede lidelserForenede Stater